His primary areas of investigation include Nuclear medicine, Radiology, Positron emission tomography, Internal medicine and PET-CT. His studies deal with areas such as Lung and Breathing as well as Nuclear medicine. In Radiology, he works on issues like Primary tumor, which are connected to Thyroid cancer and Thyroid carcinoma.
His Positron emission tomography research incorporates elements of Tomography, Carcinoma and Receiver operating characteristic. His Internal medicine research is multidisciplinary, relying on both Surgery, Oncology and Cardiology. His PET-CT research includes themes of Medical physics and Imaging technology.
His main research concerns Nuclear medicine, Internal medicine, Radiology, Positron emission tomography and Oncology. His studies examine the connections between Nuclear medicine and genetics, as well as such issues in Radiation therapy, with regards to Stage. His studies in Internal medicine integrate themes in fields like Gastroenterology, Surgery and Cardiology.
His study on PET-CT, Head and neck cancer and Tomography is often connected to In patient as part of broader study in Radiology. His Positron emission tomography research incorporates themes from Cancer, Chemoradiotherapy, Prospective cohort study and Magnetic resonance imaging. The various areas that he examines in his Oncology study include Clinical trial, Rituximab, Hazard ratio, Prostate cancer and Transplantation.
Heiko Schöder focuses on Internal medicine, Oncology, Nuclear medicine, Positron emission tomography and Cancer. His Oncology study combines topics in areas such as Rituximab, Lymphoma, Chemotherapy, Transplantation and Immunotherapy. His work carried out in the field of Nuclear medicine brings together such families of science as Lesion, Clinical trial, Head and neck cancer, Radiation therapy and Lymph.
His Positron emission tomography study contributes to a more complete understanding of Radiology. In general Radiology study, his work on Fdg pet ct often relates to the realm of In patient, thereby connecting several areas of interest. His PET-CT research includes elements of Mantle cell lymphoma, Medical physics, Biopsy and Retrospective cohort study.
Internal medicine, Nuclear medicine, Oncology, Radiation therapy and Positron emission tomography are his primary areas of study. His Nuclear medicine research is multidisciplinary, incorporating elements of Prostatectomy, Head and neck cancer, Clinical trial, Radiomics and Prostate-specific antigen. The Oncology study combines topics in areas such as Lymphoma, Rituximab, Chemotherapy, Interleukin 10 and Immunotherapy.
His study in Radiation therapy is interdisciplinary in nature, drawing from both Cancer and Cohort. His Positron emission tomography study is focused on Radiology in general. His research investigates the connection with Radiology and areas like Avidity which intersect with concerns in Pet imaging.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Evan Phillips;Oula Penate-Medina;Pat B. Zanzonico;Richard D. Carvajal.
Science Translational Medicine (2014)
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.
Wolfgang P. Fendler;Wolfgang P. Fendler;Matthias Eiber;Matthias Eiber;Mohsen Beheshti;Jamshed Bomanji.
European Journal of Nuclear Medicine and Molecular Imaging (2017)
Effect of Respiratory Gating on Quantifying PET Images of Lung Cancer
Sadek A. Nehmeh;Yusuf E. Erdi;Clifton C. Ling;Kenneth E. Rosenzweig.
The Journal of Nuclear Medicine (2002)
Four-dimensional (4D) PET/CT imaging of the thorax.
S. A. Nehmeh;Y. E. Erdi;T. Pan;A. Pevsner.
Medical Physics (2004)
Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s Lymphoma
Heiko Schöder;Ariela Noy;Mithat Gönen;Lijun Weng.
Journal of Clinical Oncology (2005)
Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion.
Heiko Schöder;Henry W. D. Yeung;Mithat Gonen;Dennis Kraus.
Positron emission tomography for prostate, bladder, and renal cancer.
Heiko Schöder;Steven M. Larson.
Seminars in Nuclear Medicine (2004)
The CT motion quantitation of lung lesions and its impact on PET-measured SUVs
Yusuf E. Erdi;Sadek A. Nehmeh;Tinsu Pan;Alexander Pevsner.
The Journal of Nuclear Medicine (2004)
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Wolfgang P Fendler;Wolfgang P Fendler;Jeremie Calais;Matthias Eiber;Matthias Eiber;Robert R Flavell.
JAMA Oncology (2019)
Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
Craig H. Moskowitz;Heiko Schöder;Julie Teruya-Feldstein;Camelia Sima.
Journal of Clinical Oncology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: